Merck & Co., Inc: Stock Set to Gain as Drug Sales Improve

  • Derek Hansen
  • 1 month ago
  • 0
Merck & Co., Inc., a global healthcare company, announced its fourth quarter 2017 revenue of $10.4bn (an increase of 3% from Q4 2016 revenue of $10.1bn) and full-year revenue of $40.1bn (an increase of 0.8% from the 2016 year revenues of $39.8bn). Its Human health business grew by 3% while Animal Health business grew by […]

Frutarom purchases 100 percent of Israeli Biotech Research (IBR) for $21 million

  • Venus Montalla
  • 3 Months ago
  • 0
Frutarom Industries Ltd., a flavoring and specialty natural ingredients company from Israel, is considered as one of the world’s largest companies of its kind. It is well known for its significant production across 150 countries worldwide and offers more than 70,000 products to over 30,000 people. Most of these products fall into the categories of […]

Moderna Therapeutics again pulled off a nine-figure financing in a new funding round

  • Venus Montalla
  • 3 Months ago
  • 0
Founded in 2010, Moderna Therapeutics is a biotech giant that specializes in mRNA technology. Basically, Moderna focuses on the creation of synthetic mRNA (ribonucleic acids), which are molecules that serve as the template for the production of proteins. The company introduces an entirely novel way of creating and administering drugs: synthetic mRNA is injected into […]

Brain and Spinal Cord Tumors in Children: An Overview of Novel Treatment Methods

  • Venus Montalla
  • 3 Months ago
  • 0
Brain and spinal cord tumors are a kind of disease wherein cells in these organs grow and divide in an abnormal manner. Having these tumors is very crucial for the brain and the spinal cord together make up the central nervous system, which is responsible for the integration of sensory information and response. In terms […]

Investor Education: How to Trade Biotech Stocks

  • Richard Cox
  • 7 Months ago
  • 0
Investor Education: How to Trade Biotech Stocks The biotechnology space is one of the most modern and exciting sectors of the market.  These are the companies that push humanity forward in the extinction of disease and treatments for illusive illnesses.  For investors, the stocks that are associated with these companies can provide some highly lucrative […]

Biotech Stocks: Amgen Rallies to New Highs

  • Richard Cox
  • 1 year ago
  • 0
The biotech industry is one of the most closely watched sectors in the stock market, and the first quarter of 2017 has been no exception to this rule.  All of the media discussion about President Trump’s repeal and replacement of Obamacare led many to believe the healthcare sector would see a major sell-off.  But when […]

Stock Trading: Gilead Sciences Ready to Reverse?

  • Richard Cox
  • 1 year ago
  • 0
Gilead Sciences, Inc. (NASDAQ: GILD) is a research-based biopharmaceutical company and one of the largest biotech entities in the world.  The company promotes a principal focus that includes the human immunodeficiency virus (HIV), liver diseases such as chronic hepatitis C virus (HCV) infection and chronic hepatitis B virus (HBV) infection, oncology and inflammation, and serious cardiovascular and […]

Financial Markets: Looking At Biotech Stocks in 2017

  • Richard Cox
  • 1 year ago
  • 0
In 2016, we saw some significant trends develop in the financial markets.  Most of the early optimism was centered in areas like precious metals, where assets like gold and silver were seeing multi-year rallies.  But these trends have clearly turned, with investors now more heavily focused on stocks — and several benchmarks have now risen […]